At Tempus AI, we're building a world where data and artificial intelligence transform how patients are treated. Founded in 2015 by Eric Lefkofsky after his wife's breast cancer diagnosis, we've grown from a small team with a singular mission into a company connecting 65% of Academic Medical Centers and 50%+ of US oncologists through our platform. Our engineers, data scientists, and healthcare experts work side-by-side to build technology that makes the world's largest library of clinical and molecular data actionable for physicians in real-time.
We're not just building software - we're creating an ecosystem that accelerates discovery of novel targets, predicts treatment effectiveness, identifies potentially life-saving clinical trials, and enables earlier diagnoses. Our culture brings together experts, innovators, cancer survivors, biologists, and data scientists who believe that the right data at the right time can change a patient's path. We optimize for impact over facetime, collaboration over hierarchy, and relentless pursuit of better outcomes. Whether it's our AI-enabled assistant Tempus One, our Lens data platform, or our genomic sequencing assays, everything we build serves one goal: ensuring patients receive the right treatment at the right time to live longer, healthier lives.